- Report
- October 2024
- 195 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- October 2024
- 189 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- October 2024
- 195 Pages
Global
From €3386EUR$3,545USD£2,831GBP
€3762EUR$3,939USD£3,146GBP
- Report
- March 2025
- 363 Pages
Global
From €5205EUR$5,450USD£4,353GBP
- Report
- February 2025
- 281 Pages
Global
From €5348EUR$5,600USD£4,472GBP
- Report
- August 2024
- 175 Pages
Global
From €4775EUR$5,000USD£3,993GBP
- Report
- September 2024
- 255 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- June 2024
- 80 Pages
United States
From €3772EUR$3,950USD£3,155GBP
- Report
- January 2023
- 197 Pages
Global
From €4889EUR$5,298USD£3,950GBP
- Report
- April 2023
- 90 Pages
Global
From €4536EUR$4,750USD£3,794GBP
- Report
- April 2023
- 175 Pages
Global
€4579EUR$4,795USD£3,830GBP

The Biological Threat market is a subset of the Biodefense industry, which focuses on the development of products and services to protect against biological threats. These threats can include naturally occurring diseases, such as pandemics, as well as intentional biological attacks. The market includes a range of products and services, such as vaccines, diagnostics, therapeutics, and decontamination systems. It also includes research and development of new technologies, such as biosecurity systems and bioterrorism detection systems.
The Biological Threat market is driven by the need to protect against the increasing threat of biological attacks and pandemics. Governments, militaries, and healthcare organizations are investing in the development of new technologies and products to protect against these threats.
Some companies in the Biological Threat market include Emergent BioSolutions, DynPort Vaccine Company, and BioThrax. Other companies include BioFire Defense, Cepheid, and BioVeris. Show Less Read more